Wedbush Reiterates Bullish Stance on Medivation (MDVN) Following STRIVE Study
Tweet Send to a Friend
Wedbush analyst David Nierengarten reiterated an Outperform rating and $138 price target on Medivation (NASDAQ: MDVN) after the company and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
